Speaker Profile

Ph.D., J.D, Partner, Fenwick & West LLP

Kevin Kabler, Ph.D., provides strategic patent counseling and due diligence to clients at all stages of the business cycle in the life sciences industry. He analyzes and evaluates third-party patents for risk reduction from assertions as well as investment purposes. He also analyzes patent portfolios for assertion and enforcement purposes against third parties. Kevin has extensive experience in developing and managing patent portfolios for companies and institutions in the life sciences industry, including preparation and prosecution of domestic and international patent applications.

Session Abstract – PMWC 2019 Silicon Valley

Session Synopsis: This session will review key developments in IP law and their impact on patent strategy with a focus on precision medicine and immuno-oncology. The session will provide background and updates on patent eligibility (section 101), tradeoffs between eligibility and the ability to effectively sue infringers. In addition, discuss legal developments that impact patent strategy for antibody or TCR-based products.

Get Exclusive Access to the Top PMWC Talks

To receive the most comprehensive news and updates from the field of precision medicine, subscribe to the newsletter here.

Bonus for suscribing, you will get the access code for the top 3 talk videos from January's Precision Medicine World Conference.

You have successfully subscribed, you can access the talks here.